|
- Methotrexate | Leukemia and Lymphoma Society
Methotrexate is FDA approved, alone or with other drugs, to treat people who have acute lymphoblastic leukemia (ALL) that has spread to the central nervous system (CNS) or to prevent ALL from spreading to the CNS
- Methotrexate for Leukemia | MyLeukemiaTeam
Methotrexate is believed to fight leukemia by interfering with cell growth and division How do I take it? Methotrexate is generally prescribed to be taken once or twice each week Methotrexate may be taken orally or by intramuscular or intravenous injection
- Methotrexate Sodium (Cancer Treatment) - NCI
Methotrexate sodium is approved to be used alone or with other drugs to treat: Acute lymphoblastic leukemia (ALL), including ALL that has spread to the central nervous system, or to prevent it from spreading there It is used in adults and children Breast cancer Gestational trophoblastic disease Head and neck cancer (certain types) Lung cancer
- Methotrexate (oral route) - Mayo Clinic
Methotrexate oral solution is used together with other medicines to treat acute lymphoblastic leukemia (ALL) or non-Hodgkin lymphoma that has come back (relapsed) or did not respond to previous treatment (refractory) It is also used alone or together with other medicines to treat mycosis fungoides
- How I treat LGL leukemia - American Society of Hematology
The authors use low-dose methotrexate initially for T-LGL leukemia patients with neutropenia and or RA We recommend either methotrexate or oral cyclophosphamide as initial therapy for anemia If treatment is not successful, patients are switched to either the other agent or cyclosporine
- Therapeutic use and toxicity of high-dose methotrexate
In 1948, aminopterin was used to induce remission in childhood acute lymphoblastic leukemia (ALL), and the related agent methotrexate (MTX) is still an important component of modern treatment for ALL as well as a number of other hematologic malignancies [1]
- Which Types of Cancer is Methotrexate Used For?
Methotrexate is used to treat a variety of cancers, including breast cancer, lung cancer, head and neck cancers, and leukemia It is also used in high-dose regimens for certain types of non-Hodgkin lymphoma and osteosarcoma
- Methotrexate therapy of T-cell large granular lymphocytic leukemia . . .
T-cell large granular lymphocytic leukemia (T-LGLL) is a rare haematologic neoplasm Consequntly, there are no large prospective studies of therapy and no uniform therapy recommendations We analyzed data from 36 subjects receiving methotrexate
|
|
|